274 related articles for article (PubMed ID: 35095906)
1. IL-17 Aggravates
Ding F; Han L; Fu Q; Fan X; Tang R; Lv C; Xue Y; Tian X; Zhang M
Front Immunol; 2021; 12():811803. PubMed ID: 35095906
[No Abstract] [Full Text] [Related]
2. IL-17 Promotes
Me R; Gao N; Dai C; Yu FX
J Immunol; 2020 Jan; 204(1):169-179. PubMed ID: 31767781
[TBL] [Abstract][Full Text] [Related]
3. IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa.
Lorè NI; Cigana C; Riva C; De Fino I; Nonis A; Spagnuolo L; Sipione B; Cariani L; Girelli D; Rossi G; Basso V; Colombo C; Mondino A; Bragonzi A
Sci Rep; 2016 May; 6():25937. PubMed ID: 27189736
[TBL] [Abstract][Full Text] [Related]
4. Tracking the response to Pseudomonas aeruginosa infection in ozone-induced chronic obstructive pulmonary disease mouse models.
Han L; Huang Y; Fu Q; Xue Y; Ding F; Zhang M
Biomed Pharmacother; 2022 Jun; 150():112980. PubMed ID: 35453008
[TBL] [Abstract][Full Text] [Related]
5. Targeting IL-1β and IL-17A driven inflammation during influenza-induced exacerbations of chronic lung inflammation.
Sichelstiel A; Yadava K; Trompette A; Salami O; Iwakura Y; Nicod LP; Marsland BJ
PLoS One; 2014; 9(2):e98440. PubMed ID: 24918427
[TBL] [Abstract][Full Text] [Related]
6. Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.
Mallia P; Webber J; Gill SK; Trujillo-Torralbo MB; Calderazzo MA; Finney L; Bakhsoliani E; Farne H; Singanayagam A; Footitt J; Hewitt R; Kebadze T; Aniscenko J; Padmanaban V; Molyneaux PL; Adcock IM; Barnes PJ; Ito K; Elkin SL; Kon OM; Cookson WO; Moffat MF; Johnston SL; Tregoning JS
J Allergy Clin Immunol; 2018 Sep; 142(3):815-823.e6. PubMed ID: 29310905
[TBL] [Abstract][Full Text] [Related]
7. IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Roos AB; Sethi S; Nikota J; Wrona CT; Dorrington MG; Sandén C; Bauer CM; Shen P; Bowdish D; Stevenson CS; Erjefält JS; Stampfli MR
Am J Respir Crit Care Med; 2015 Aug; 192(4):428-37. PubMed ID: 26039632
[TBL] [Abstract][Full Text] [Related]
8. TSLP Protects Corneas From Pseudomonas aeruginosa Infection by Regulating Dendritic Cells and IL-23-IL-17 Pathway.
Cui X; Gao N; Me R; Xu J; Yu FX
Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4228-4237. PubMed ID: 30128494
[TBL] [Abstract][Full Text] [Related]
9. Cigarette smoke decreases airway epithelial FABP5 expression and promotes Pseudomonas aeruginosa infection.
Gally F; Chu HW; Bowler RP
PLoS One; 2013; 8(1):e51784. PubMed ID: 23349676
[TBL] [Abstract][Full Text] [Related]
10. IL-17A attracts inflammatory cells in murine lung infection with P. aeruginosa.
Wonnenberg B; Jungnickel C; Honecker A; Wolf L; Voss M; Bischoff M; Tschernig T; Herr C; Bals R; Beisswenger C
Innate Immun; 2016 Nov; 22(8):620-625. PubMed ID: 27634821
[TBL] [Abstract][Full Text] [Related]
11. Targeting IL-17A/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases.
Ouyang S; Liu C; Xiao J; Chen X; Lui AC; Li X
JCI Insight; 2020 Feb; 5(3):. PubMed ID: 32051346
[TBL] [Abstract][Full Text] [Related]
12. [Interventional effect of IL-17A on chronic obstructive pulmonary disease and its mechanism].
Bai LL; Wang ZH; Ning XC; Gong CK; Li AM; Duan YL; Jiao YJ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov; 37(6):584-588. PubMed ID: 34821088
[No Abstract] [Full Text] [Related]
13. Serum amyloid A promotes lung neutrophilia by increasing IL-17A levels in the mucosa and γδ T cells.
Anthony D; Seow HJ; Uddin M; Thompson M; Dousha L; Vlahos R; Irving LB; Levy BD; Anderson GP; Bozinovski S
Am J Respir Crit Care Med; 2013 Jul; 188(2):179-86. PubMed ID: 23627303
[TBL] [Abstract][Full Text] [Related]
14. A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection.
Tiringer K; Treis A; Fucik P; Gona M; Gruber S; Renner S; Dehlink E; Nachbaur E; Horak F; Jaksch P; Döring G; Crameri R; Jung A; Rochat MK; Hörmann M; Spittler A; Klepetko W; Akdis CA; Szépfalusi Z; Frischer T; Eiwegger T
Am J Respir Crit Care Med; 2013 Mar; 187(6):621-9. PubMed ID: 23306544
[TBL] [Abstract][Full Text] [Related]
15. Role of IL-17A in murine models of COPD airway disease.
Yanagisawa H; Hashimoto M; Minagawa S; Takasaka N; Ma R; Moermans C; Ito S; Araya J; Budelsky A; Goodsell A; Baron JL; Nishimura SL
Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L122-L130. PubMed ID: 27913421
[TBL] [Abstract][Full Text] [Related]
16. Microbiota Promotes Chronic Pulmonary Inflammation by Enhancing IL-17A and Autoantibodies.
Yadava K; Pattaroni C; Sichelstiel AK; Trompette A; Gollwitzer ES; Salami O; von Garnier C; Nicod LP; Marsland BJ
Am J Respir Crit Care Med; 2016 May; 193(9):975-87. PubMed ID: 26630356
[TBL] [Abstract][Full Text] [Related]
17. Roflumilast Increases Bacterial Load and Dissemination in a Model of Pseudomononas Aeruginosa Airway Infection.
Kasetty G; Papareddy P; Bhongir RK; Egesten A
J Pharmacol Exp Ther; 2016 Apr; 357(1):66-72. PubMed ID: 26865680
[TBL] [Abstract][Full Text] [Related]
18. Impairment in inflammasome signaling by the chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients results in an increase in inflammatory response.
Phuong MS; Hernandez RE; Wolter DJ; Hoffman LR; Sad S
Cell Death Dis; 2021 Mar; 12(3):241. PubMed ID: 33664232
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin-1 Restricts Interleukin-36γ-Mediated Neutrophilic Inflammation during Pseudomonas aeruginosa Pulmonary Infection.
Peñaloza HF; Olonisakin TF; Bain WG; Qu Y; van der Geest R; Zupetic J; Hulver M; Xiong Z; Newstead MW; Zou C; Alder JK; Ybe JA; Standiford TJ; Lee JS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824208
[TBL] [Abstract][Full Text] [Related]
20. Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections.
Valenti P; Frioni A; Rossi A; Ranucci S; De Fino I; Cutone A; Rosa L; Bragonzi A; Berlutti F
Biochem Cell Biol; 2017 Feb; 95(1):41-47. PubMed ID: 28129511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
